[68Ga]Ga-OncoACP3 PET imaging defines acid phosphatase 3 as a clinically actionable theranostic target in prostate cancer: a prospective phase I trial. // The EANM Journal. – URL: https://www.sciencedirect.com/science/article/pii/S3051292126002198?dgcid=rss_sd_all
[68Ga]Ga-OncoACP3 PET imaging defines acid phosphatase 3 as a clinically actionable theranostic target in prostate cancer: a prospective phase I trial. The EANM Journal. https://www.sciencedirect.com/science/article/pii/S3051292126002198?dgcid=rss_sd_all
“[68Ga]Ga-OncoACP3 PET imaging defines acid phosphatase 3 as a clinically actionable theranostic target in prostate cancer: a prospective phase I trial.” The EANM Journal.
@article{article67784,
title = {[68Ga]Ga-OncoACP3 PET imaging defines acid phosphatase 3 as a clinically actionable theranostic target in prostate cancer: a prospective phase I trial},
journal = {The EANM Journal},
url = {https://www.sciencedirect.com/science/article/pii/S3051292126002198?dgcid=rss_sd_all}
}